FDA accepts Merck's SAFLUTAN NDA for standard review
Links shared publicly online about this topic.
- 450total visits
FDA accepts Merck's SAFLUTAN NDA for standard review
View full resource at news-medical.net
Tags: Diet and Nutrition, Drug, FDA, Merck & Co.
Most Recently Shared on March 12, 2011 at 7:26 pm By:
FDA accepts Merck's SAFLUTAN NDA for standard review: Merck, known as MSD outside the United States and Canada, ... http://bit.ly/g9Ozy6
FDA accepts NDA for extended-release Janumet for type 2 diabetes - MPR
empr.com — “Merck announced that the New Drug Application (NDA) for its investigational extended-release formulation of Janumet (sitagliptin/metformin HCI) for type 2 diabetes has been accepted for standard review by the FDA.” View full resource at empr.com
Most Recently Shared on January 13, 2011 at 3:38 pm By:
MPR News: FDA accepts NDA for extended-release Janumet for type 2 diabetes: Merck announced that the New Drug Ap... http://bit.ly/hVcolP
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(R) For Type 2 Diabetes
medicalnewstoday.com — “Merck announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S.” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2011 at 3:05 pm By:
Merck Announces FDA Acceptance Of New Drug Application For An Investigational Extended-Release Formulation Of JANUMET(... http://mnt.to/3PWH
Advertisement
